Iloprost

Synonyms: 伊洛前列素; Ciloprost; ZK 36374
Iloprost(ZK 36374;Ciloprost)是一种参与胚胎发育和炎症改善并抑制肿瘤转移的前列环素 PGI2 类似物,可用于外周血管疾病的研究。
产品编号: MS-G47869 纯度: 98.32% CAS No.: 78919-13-8 分子式: C22H32O4 分子量: 360.49
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
询价
2mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
200mg
询价
询价

产品描述

Iloprost(ZK 36374;Ciloprost)是一种参与胚胎发育和炎症改善并抑制肿瘤转移的前列环素 PGI2 类似物,可用于外周血管疾病的研究。

生物实验数据

生物活性 Iloprost (ZK 36374; Ciloprost) is a prostacyclin PGI2 analog that is involved in embryonic development and inflammation improvement and inhibits tumor metastasis, and it can be used for research on peripheral vascular diseases.
IC50 & Target

IP

 

体外研究
(In Vitro)

Prostacyclin (PGI2) is synthesised in oviductal fluid and enhance the embryo development.
Iloprost is an PGI2 analog, and affects maturation and developmental competence of bovine oocytes.
Iloprost (0.5 μM; 22-24 h) increases blastocyst rates of bovine embryos as well as proportion of expanded blastocysts.
Iloprost (0.5 μM; 22-24 h) assists maturation rates and cumulus cell expansion of bovine oocytes, and increases the mRNA expression of genes related to cumulus expansion.
Iloprost (0.5 μM; 22-24 h) reduces the occurrence of apoptosis in COCs and promotes an anti-apoptotic balance in the transcription of genes involved in apoptosis (BAX and BCL2).

RT-PCR

Cell Line: Bovine oocytes: cumulus oocyte complexes (COCs)
Concentration: 0.5 μM
Incubation Time: 22-24 hours
Result: Increased mRNA expression levels of cysteine proteinases cathepsins, including ADAM17, AREG, and TNFAIP6 23 and cathepsin genes (CTSK and CTSS).
体内研究
(In Vivo)

Iloprost (0.3 mg/kg/min; via s.c. mini pumps; 33 d) has a significant anti-metastatic activity in a spontaneously metastasizing tumor model in rat.
Iloprost (0.2 mg/kg/d; i.p.; 10 d) attenuates hyperoxia effects and reduces inflammation in the newborn mouse lung, with Cyclooxygenase-2 (COX-2/PTGS2) mediates hyperoxia-induced impairment.
Iloprost (0.2 mg/kg; i.v. or i.p.) exhibits short half-life, and is often administered by means of frequent (every 2-4h) inhalation in treatment.
Comparison of pharmacokinetic parameter in rats and mice

Animal Route Dose (mg/kg) AUC (ng•h/mL) F (%) CL (range) (mL/min/kg) t1/2λi (min) t1/2λz (min)
Mice i.v. 0.2 21.9 100 152 3 15
Rat i.g. 0.2 2.2 10 / 4 58

Animal Model: Spontaneously metastasizing R 3327 MAT Lu prostate carcinoma in Cop rat
Dosage: 0.3 mg/kg/min
Administration: Subcutaneous administration via Alzet mini pumps; continuously for 33 days
Result: Reduced the number of visible lung metastases, but had no effect on the growth of the primary tumor.
This action was based on the ability to reduce the attachment of tumor cells to platelets and to inhibit adhesion of tumor cells-platelet aggregates to the endothelial lining.
Animal Model: Newborn C57BL/6 mice (4-day-old)
Dosage: 0.2 mg/kg
Administration: Intraperitoneal injection; once daily; 10 days
Result: Reduced markedly pro-inflammatory cytokines IL-1β and TNF-α mRNA and protein.
Inhibited alveolar septation, reduced hyperoxia-induced total lung resistance and myeloperoxidase, prevented hyperoxia-reduced lung microvascular density.
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT07498309University Hospital, Rouen
Vaso-Occlusive Crises|Sickle Cell Disease
2026-09PHASE3
NCT02490657Yonsei University
Video-assisted Thoracoscopic Surgery|Chronic Obstructive Pulmonary Disease
2015-07NA
NCT05411107National Cancer Institute (NCI)
Bronchial Epithelial Dysplasia|Chronic Obstructive Pulmonary Disease|Lung Carcinoma|Stage I Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Tobacco-Related Carcinoma
2024-06-01PHASE2
性状 油状物
颜色 Colorless to light yellow

化学信息

分子量 360.49
分子式 C22H32O4
CAS No. 78919-13-8
别名 伊洛前列素; Ciloprost; ZK 36374

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (9.15 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Pure form -20°C 3 years
In solvent -80°C 2 years
-20°C 1 year
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (277.40 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.7740 mL13.8700 mL27.7400 mL69.3501 mL
5 mM0.5548 mL2.7740 mL5.5480 mL13.8700 mL
10 mM0.2774 mL1.3870 mL2.7740 mL6.9350 mL
15 mM0.1849 mL0.9247 mL1.8493 mL4.6233 mL
20 mM0.1387 mL0.6935 mL1.3870 mL3.4675 mL
25 mM0.1110 mL0.5548 mL1.1096 mL2.7740 mL
30 mM0.0925 mL0.4623 mL0.9247 mL2.3117 mL
40 mM0.0694 mL0.3468 mL0.6935 mL1.7338 mL
50 mM0.0555 mL0.2774 mL0.5548 mL1.3870 mL
60 mM0.0462 mL0.2312 mL0.4623 mL1.1558 mL
80 mM0.0347 mL0.1734 mL0.3468 mL0.8669 mL
100 mM0.0277 mL0.1387 mL0.2774 mL0.6935 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础